rs121912436
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000454.5(SOD1):c.256G>A(p.Gly86Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G86R) has been classified as Pathogenic.
Frequency
Consequence
NM_000454.5 missense
Scores
Clinical Significance
Conservation
Publications
- amyotrophic lateral sclerosis type 1Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- spastic tetraplegia and axial hypotonia, progressiveInheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- amyotrophic lateral sclerosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SOD1 | NM_000454.5 | c.256G>A | p.Gly86Ser | missense_variant | Exon 4 of 5 | ENST00000270142.11 | NP_000445.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Amyotrophic lateral sclerosis type 1 Pathogenic:1
This missense change has been observed in individual(s) with amyotrophic lateral sclerosis (PMID: 20075587, 29982983). This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 86 of the SOD1 protein (p.Gly86Ser). This variant is not present in population databases (gnomAD no frequency). This variant is also known as G85S. ClinVar contains an entry for this variant (Variation ID: 932081). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SOD1 protein function. Experimental studies have shown that this missense change affects SOD1 function (PMID: 23280792). This variant disrupts the p.Gly86 amino acid residue in SOD1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 15050437, 15208263, 16945901, 20472325). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
SOD1-related disorder Pathogenic:1
The SOD1 c.256G>A variant is predicted to result in the amino acid substitution p.Gly86Ser. This variant was reported in an individual with familial amyotrophic lateral sclerosis (Takazawa et al 2010. PubMed ID: 20075587). A different missense change at the same amino acid position, c.256G>C (p.Gly86Arg) has previously been reported to be causative for ALS (Rosen et al 1993. PubMed ID: 8446170; Table S2 Chen W et al 2020. PubMed ID: 32166880). This gene has a low rate of benign missense variation and missense variants are a common mechanism of disease. This variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as likely pathogenic. -
Spastic tetraplegia and axial hypotonia, progressive Pathogenic:1
This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PP4,PP3,PP2,PM2,PM1,PS1,PS3. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at